Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Annual updates take effect on October 1 each fiscal year
Allyson Dailey, and Dr
The primary advantages of GLP-1RAs lie in glucose reduction, cardiorenal benefits, and amelioration of metabolic syndrome, all of which are substantiated by a plethora of evidence-based studies [1,2,3,4]
Book a Consultation Projections are based on the ATTAIN-MAINTAIN Phase 3 clinical trial (Eli Lilly, December 2025), which measured the average percentage of lost weight regained when patients switched from injectable GLP-1 medications to Foundayo over 52 weeks
US$ 25.22
US$ 28.35
.jpg)
US$ 28.23
US$ 21.48
US$ 25.82
